RUBINSTEIN JULIE
President and COO
- Shares
- 11,881
- Price
- $28.27
- Value
- $335,876
ADPT
7 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$29,898,097
0 buyers · 7 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$113,202,118
11 distinct insiders
Highlighted alerts
10
90 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ADPT overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.04 to $27.02, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.98, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.85 to $28.84, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.88 to $28.92, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.92 to $28.73, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. The option is fully vested and exercisable.
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Voluntary purchases and sales; administrative noise stays hidden.
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
BOBULSKY SUSAN
Chief Commercial Officer, MRD
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
LO FRANCIS
Chief People Officer
LO FRANCIS
Chief People Officer
LO FRANCIS
Chief People Officer
LO FRANCIS
Chief People Officer
BOBULSKY SUSAN
Chief Commercial Officer, MRD
OWEN KATEY EINTERZ
Director
ROBINS CHAD M
CEO and Chairman
ROBINS CHAD M
CEO and Chairman
HERSHBERG ROBERT
Director
HERSHBERG ROBERT
Director
ROBINS CHAD M
CEO and Chairman
ROBINS CHAD M
CEO and Chairman
NEUPERT PETER M
Director
NEUPERT PETER M
Director
NEUPERT PETER M
Director
BOBULSKY SUSAN
Chief Commercial Officer, MRD
BOBULSKY SUSAN
Chief Commercial Officer, MRD
ROBINS HARLAN S
Chief Scientific Officer
ROBINS HARLAN S
Chief Scientific Officer
BOBULSKY SUSAN
Chief Commercial Officer, MRD
LO FRANCIS
Chief People Officer
ROBINS HARLAN S
Chief Scientific Officer
ROBINS HARLAN S
Chief Scientific Officer
LO FRANCIS
Chief People Officer
BOBULSKY SUSAN
Chief Commercial Officer, MRD
LO FRANCIS
Chief People Officer
LO FRANCIS
Chief People Officer
BENZENO SHARON
Chief Commercial Ofc Imm Med
BENZENO SHARON
Chief Commercial Ofc Imm Med
BOBULSKY SUSAN
Chief Commercial Officer, MRD
GRIFFIN MICHELLE RENEE
Director
ROBINS HARLAN S
Chief Scientific Officer
ROBINS HARLAN S
Chief Scientific Officer
BOBULSKY SUSAN
Chief Commercial Officer, MRD
BOBULSKY SUSAN
Chief Commercial Officer, MRD
LO FRANCIS
Chief People Officer
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
ROBINS HARLAN S
Chief Scientific Officer
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
LO FRANCIS
Chief People Officer
ROBINS CHAD M
CEO and Chairman
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
ROBINS CHAD M
CEO and Chairman
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
RUBINSTEIN JULIE
President and COO
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $28.27 | $335,876 | |
| Oct 28, 2026 | RUBINSTEIN JULIE President and COO | Sale | 200 | $28.90 | $5,780 | |
| Oct 28, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,681 | $28.44 | $332,208 | |
| Oct 27, 2026 | RUBINSTEIN JULIE President and COO | Sale | 8,881 | $27.53 | $244,494 | |
| Oct 27, 2026 | RUBINSTEIN JULIE President and COO | Sale | 3,000 | $26.58 | $79,740 | |
| Oct 26, 2026 | RUBINSTEIN JULIE President and COO | Sale | 3,378 | $26.30 | $88,841 | |
| Oct 26, 2026 | RUBINSTEIN JULIE President and COO | Sale | 8,503 | $25.94 | $220,568 | |
| Oct 23, 2026 | RUBINSTEIN JULIE President and COO | Sale | 7,381 | $25.28 | $186,592 | |
| Oct 23, 2026 | RUBINSTEIN JULIE President and COO | Sale | 4,500 | $24.50 | $110,250 | |
| Oct 22, 2026 | RUBINSTEIN JULIE President and COO | Sale | 1,700 | $25.29 | $42,993 | |
| Oct 22, 2026 | RUBINSTEIN JULIE President and COO | Sale | 10,181 | $24.38 | $248,213 | |
| Oct 21, 2026 | RUBINSTEIN JULIE President and COO | Sale | 5,882 | $25.57 | $150,403 | |
| Oct 21, 2026 | RUBINSTEIN JULIE President and COO | Sale | 5,999 | $25.25 | $151,475 | |
| Oct 20, 2026 | RUBINSTEIN JULIE President and COO | Sale | 100 | $24.85 | $2,485 | |
| Oct 20, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,781 | $24.53 | $288,988 | |
| Oct 19, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $24.05 | $285,738 | |
| Oct 16, 2026 | RUBINSTEIN JULIE President and COO | Sale | 300 | $25.45 | $7,635 | |
| Oct 16, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,581 | $24.21 | $280,376 | |
| Oct 15, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $25.61 | $304,272 | |
| Oct 14, 2026 | RUBINSTEIN JULIE President and COO | Sale | 5,100 | $25.82 | $131,682 | |
| Oct 14, 2026 | RUBINSTEIN JULIE President and COO | Sale | 6,781 | $25.57 | $173,390 | |
| Oct 13, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $25.50 | $302,966 | |
| Oct 12, 2026 | RUBINSTEIN JULIE President and COO | Sale | 2,700 | $26.07 | $70,389 | |
| Oct 12, 2026 | RUBINSTEIN JULIE President and COO | Sale | 9,181 | $25.35 | $232,738 | |
| Oct 09, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $26.41 | $313,777 | |
| Oct 08, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $25.66 | $304,866 | |
| Oct 07, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $26.40 | $313,658 | |
| Oct 06, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 6,444 | $30.00 | $193,320 | |
| Oct 06, 2026 | RUBINSTEIN JULIE President and COO | Sale | 499 | $30.53 | $15,234 | |
| Oct 06, 2026 | RUBINSTEIN JULIE President and COO | Sale | 901 | $29.71 | $26,769 | |
| Oct 06, 2026 | RUBINSTEIN JULIE President and COO | Sale | 1,100 | $28.21 | $31,031 | |
| Oct 06, 2026 | RUBINSTEIN JULIE President and COO | Sale | 9,381 | $27.36 | $256,664 | |
| Oct 05, 2026 | RUBINSTEIN JULIE President and COO | Sale | 5,182 | $29.67 | $153,750 | |
| Oct 05, 2026 | RUBINSTEIN JULIE President and COO | Sale | 6,699 | $28.82 | $193,065 | |
| Oct 02, 2026 | RUBINSTEIN JULIE President and COO | Sale | 11,881 | $28.13 | $334,213 | |
| Oct 01, 2026 | RUBINSTEIN JULIE President and COO | Sale | 5,800 | $28.56 | $165,648 | |
| Oct 01, 2026 | RUBINSTEIN JULIE President and COO | Sale | 6,081 | $27.57 | $167,653 | |
| Oct 01, 2026 | LO FRANCIS Chief People Officer | Sale | 18,698 | $28.61 | $534,950 | |
| Oct 01, 2026 | LO FRANCIS Chief People Officer | Sale | 8,094 | $27.52 | $222,747 | |
| Sep 16, 2026 | LO FRANCIS Chief People Officer | Sale | 7,869 | $28.57 | $224,817 | |
| Sep 16, 2026 | LO FRANCIS Chief People Officer | Sale | 107,537 | $28.02 | $3,013,187 | |
| Sep 15, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 1,195 | $27.00 | $32,265 | |
| Aug 26, 2026 | OWEN KATEY EINTERZ Director | Sale | 9,615 | $26.00 | $249,990 | |
| Aug 18, 2026 | ROBINS CHAD M CEO and Chairman | Sale | 204 | $25.14 | $5,129 | |
| Aug 18, 2026 | ROBINS CHAD M CEO and Chairman | Sale | 278,472 | $24.48 | $6,816,995 | |
| Aug 18, 2026 | HERSHBERG ROBERT Director | Sale | 15,664 | $24.41 | $382,358 | |
| Aug 18, 2026 | HERSHBERG ROBERT Director | Sale | 15,000 | $24.39 | $365,850 | |
| Aug 17, 2026 | ROBINS CHAD M CEO and Chairman | Sale | 2,525 | $25.57 | $64,564 | |
| Aug 17, 2026 | ROBINS CHAD M CEO and Chairman | Sale | 318,799 | $25.08 | $7,995,479 | |
| Aug 17, 2026 | NEUPERT PETER M Director | Sale | 69,690 | $25.16 | $1,753,400 | |
| Aug 17, 2026 | NEUPERT PETER M Director | Sale | 40,000 | $25.10 | $1,004,000 | |
| Aug 17, 2026 | NEUPERT PETER M Director | Sale | 15,000 | $25.23 | $378,450 | |
| Aug 10, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 3,000 | $25.00 | $75,000 | |
| Jul 30, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 1,299 | $24.00 | $31,176 | |
| Jul 21, 2026 | ROBINS HARLAN S Chief Scientific Officer | Sale | 213,702 | $22.12 | $4,727,088 | |
| Jul 21, 2026 | ROBINS HARLAN S Chief Scientific Officer | Sale | 278,698 | $21.72 | $6,053,321 | |
| Jul 16, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 5,000 | $23.00 | $115,000 | |
| Jul 15, 2026 | LO FRANCIS Chief People Officer | Sale | 105,762 | $22.59 | $2,389,164 | |
| Jul 02, 2026 | ROBINS HARLAN S Chief Scientific Officer | Sale | 146,889 | $22.45 | $3,297,658 | |
| Jul 02, 2026 | ROBINS HARLAN S Chief Scientific Officer | Sale | 239,351 | $21.74 | $5,203,491 | |
| Jul 02, 2026 | LO FRANCIS Chief People Officer | Sale | 44,838 | $22.59 | $1,012,890 | |
| Jul 01, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 487 | $22.00 | $10,714 | |
| Jul 01, 2026 | LO FRANCIS Chief People Officer | Sale | 42,261 | $22.50 | $950,873 | |
| Jul 01, 2026 | LO FRANCIS Chief People Officer | Sale | 8,743 | $22.18 | $193,920 | |
| Jun 29, 2026 | BENZENO SHARON Chief Commercial Ofc Imm Med | Sale | 154,768 | $21.14 | $3,271,796 | |
| Jun 26, 2026 | BENZENO SHARON Chief Commercial Ofc Imm Med | Sale | 11,034 | $21.00 | $231,714 | |
| Jun 25, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 5,000 | $20.50 | $102,500 | |
| Jun 25, 2026 | GRIFFIN MICHELLE RENEE Director | Sale | 52,084 | $20.18 | $1,051,055 | |
| Jun 16, 2026 | ROBINS HARLAN S Chief Scientific Officer | Sale | 6,160 | $18.01 | $110,942 | |
| Jun 15, 2026 | ROBINS HARLAN S Chief Scientific Officer | Sale | 100,000 | $17.37 | $1,737,000 | |
| Jun 11, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 5,000 | $19.00 | $95,000 | |
| Jun 04, 2026 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale | 11,000 | $18.00 | $198,000 | |
| Jun 04, 2026 | LO FRANCIS Chief People Officer | Sale | 39,741 | $17.49 | $695,070 | |
| Apr 27, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,037 | $14.23 | $270,897 | |
| Apr 24, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.02 | $267,221 | |
| Apr 23, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $13.74 | $261,884 | |
| Apr 22, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.13 | $269,318 | |
| Apr 21, 2026 | RUBINSTEIN JULIE President and COO | Sale | 30,941 | $14.66 | $453,595 | |
| Apr 20, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.55 | $277,323 | |
| Apr 17, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.57 | $277,704 | |
| Apr 16, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.18 | $270,271 | |
| Apr 15, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.61 | $278,467 | |
| Apr 14, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.56 | $277,514 | |
| Apr 13, 2026 | RUBINSTEIN JULIE President and COO | Sale | 3,338 | $14.08 | $46,999 | |
| Apr 13, 2026 | RUBINSTEIN JULIE President and COO | Sale | 15,722 | $12.95 | $203,600 | |
| Apr 10, 2026 | RUBINSTEIN JULIE President and COO | Sale | 400 | $13.48 | $5,392 | |
| Apr 10, 2026 | RUBINSTEIN JULIE President and COO | Sale | 18,660 | $12.75 | $237,915 | |
| Apr 09, 2026 | RUBINSTEIN JULIE President and COO | Sale | 2,100 | $14.44 | $30,324 | |
| Apr 09, 2026 | RUBINSTEIN JULIE President and COO | Sale | 16,960 | $13.79 | $233,878 | |
| Apr 08, 2026 | ROBINS HARLAN S Chief Scientific Officer | Sale | 10,000 | $14.85 | $148,500 | |
| Apr 08, 2026 | RUBINSTEIN JULIE President and COO | Sale | 100 | $15.48 | $1,548 | |
| Apr 08, 2026 | RUBINSTEIN JULIE President and COO | Sale | 30,841 | $14.83 | $457,372 | |
| Apr 08, 2026 | LO FRANCIS Chief People Officer | Sale | 22,564 | $15.07 | $340,039 | |
| Apr 08, 2026 | ROBINS CHAD M CEO and Chairman | Sale | 37,263 | $15.19 | $566,025 | |
| Apr 07, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $13.56 | $258,454 | |
| Apr 06, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.33 | $273,130 | |
| Apr 06, 2026 | ROBINS CHAD M CEO and Chairman | Sale | 83,332 | $14.41 | $1,200,814 | |
| Apr 02, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.60 | $278,276 | |
| Apr 01, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $14.45 | $275,417 | |
| Mar 31, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $13.45 | $256,357 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.